NCT06647238View on ClinicalTrials.gov

Evaluation of Pharmacist Interventions in Lipid Management for Secondary Prevention

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 5, 2024

Primary Completion Date

May 1, 2025

Study Completion Date

May 27, 2025

Conditions

HyperlipidemiaCoronary Artery Disease

Interventions

OTHER

Pharmacist Intervention in lipid therapy

Pharmacist intervention may include but is not limited to prescribing (statins, ezetimibe, bempedoic acid, PCSK9 inhibitors, etc.), patient education, and medication access.

Trial Locations (1)

28025

Atrium Health Cabarrus, Concord

All Listed Sponsors

lead

Wake Forest University Health Sciences

OTHER

NCT06647238 - Evaluation of Pharmacist Interventions in Lipid Management for Secondary Prevention | Biotech Hunter | Biotech Hunter